AzurRx BioPharma Inc. Shares Close the Week 35.5% Higher - Weekly Wrap

The company saw its shares close the week 35.5% higher than last week, with trading volume higher than its 30 day average.

Mar 12, 2021 by Kwhen Finance Editors

AzurRx BioPharma Inc. Shares Close the Week 35.5% Higher - Weekly Wrap
AzurRx BioPharma Inc. shares closed this week 35.5% higher than it did at the end of last week. The stock is currently up 73.2% year-to-date, up 236.0% over the past 12 months, and down 66.3% over the past five years. This week, the Dow Jones Industrial Average rose 3.7%, and the S&P 500 rose 2.3%.

Trading Activity

  • Shares traded as high as $1.86 and as low as $1.21 this week.
  • Trading volume this week was 166.1% higher than the 10-day average and 437.4% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.4.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
AzurRx BioPharma Inc.7.173.2236.0
Dow Jones Industrial Average-0.48.245.2-0.184.4
S&P 500 Index-0.15.968.1-0.284.2
Health Care0.72.046.7-3.362.2

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 654.2%
  • The company's stock price performance over the past 12 months beats the peer average by 1955.7%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
AzurRx BioPharma Inc.AZRX073.2236.0
Peer AvgN/A-2.29.711.5-18.946.1
Omeros CorporationOMER-8.939.463.1-16.4132.9
Odonate Therapeutics Inc.ODT0-0.6-17.2-59.151.4

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: